Shirouchi, B.; Mitsuta, S.; Higuchi, M.; Okumura, M.; Tanaka, K.
Dietary Nicotinamide Mononucleotide, a Key NAD+ Intermediate Alleviates Body Fat Mass and Hypertriglyceridemia by Enhancing Energy Expenditure with Promotion of Fat Oxidation and Hepatic Lipolysis and Suppressing Hepatic Lipogenesis in db/db Mice. Metabolites 2025, 15, 333.
https://doi.org/10.3390/metabo15050333
AMA Style
Shirouchi B, Mitsuta S, Higuchi M, Okumura M, Tanaka K.
Dietary Nicotinamide Mononucleotide, a Key NAD+ Intermediate Alleviates Body Fat Mass and Hypertriglyceridemia by Enhancing Energy Expenditure with Promotion of Fat Oxidation and Hepatic Lipolysis and Suppressing Hepatic Lipogenesis in db/db Mice. Metabolites. 2025; 15(5):333.
https://doi.org/10.3390/metabo15050333
Chicago/Turabian Style
Shirouchi, Bungo, Sarasa Mitsuta, Mina Higuchi, Mai Okumura, and Kazunari Tanaka.
2025. "Dietary Nicotinamide Mononucleotide, a Key NAD+ Intermediate Alleviates Body Fat Mass and Hypertriglyceridemia by Enhancing Energy Expenditure with Promotion of Fat Oxidation and Hepatic Lipolysis and Suppressing Hepatic Lipogenesis in db/db Mice" Metabolites 15, no. 5: 333.
https://doi.org/10.3390/metabo15050333
APA Style
Shirouchi, B., Mitsuta, S., Higuchi, M., Okumura, M., & Tanaka, K.
(2025). Dietary Nicotinamide Mononucleotide, a Key NAD+ Intermediate Alleviates Body Fat Mass and Hypertriglyceridemia by Enhancing Energy Expenditure with Promotion of Fat Oxidation and Hepatic Lipolysis and Suppressing Hepatic Lipogenesis in db/db Mice. Metabolites, 15(5), 333.
https://doi.org/10.3390/metabo15050333
